Get an alert when SYNEOS HEALTH COMMERCIAL EUROPE LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-01-31 (in 8mo)

Last made up 2026-01-17

Watchouts

None on the register

Cash

£42K

-99.5% vs 2023

Net assets

-£16M

+63.3% vs 2023

Employees

78

+20% vs 2023

Profit before tax

-£2M

-1,582% vs 2023

Name history

Renamed 1 time since incorporation

  1. SYNEOS HEALTH COMMERCIAL EUROPE LIMITED 2019-07-10 → present
  2. INVENTIV HEALTH COMMERCIAL EUROPE LTD 2014-01-17 → 2019-07-10

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £15,489,000£20,640,000
Operating profit £2,715,000-£537,000
Profit before tax -£128,000-£2,153,000
Net profit -£128,000-£2,153,000
Cash £8,052,000£42,000
Total assets less current liabilities -£44,008,000-£16,161,000
Net assets -£44,008,000-£16,161,000
Equity -£44,008,000-£16,161,000
Average employees 6578
Wages £6,517,000£7,170,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 17.5%-2.6%
Net margin -0.8%-10.4%
Return on capital employed -6.2%3.3%
Current ratio 0.27x0.29x
Interest cover 0.95x-0.33x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Forvis Mazars LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Whilst the company has net liabilities, the company receives ongoing support from Star Intermediate Holdings, Inc., which has itself concluded that it has sufficient liquidity to continue trading...the director has assessed and concluded that Star Intermediate Holdings, Inc. has sufficient funds to support the company for the foreseeable future, deemed to be a period of at least 12 months from the approval of the accounts. Accordingly, the accompanying financial statements have been prepared on the assumption that the company will continue as a going concern.”

Group structure

  1. SYNEOS HEALTH COMMERCIAL EUROPE LIMITED · parent
    1. Sharpview Ophthalmology Limited 49% · United Kingdom

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 11 resigned

Name Role Appointed Born Nationality
CITCO MANAGEMENT (UK) LIMITED Corporate Secretary 2024-09-01
MOUSSALLY, Philip Peter Director 2020-03-09 Aug 1975 American
Show 11 resigned officers
Name Role Appointed Resigned
CITCO MANAGEMENT (UK) LIMITED Corporate Secretary 2014-01-17 2018-07-16
TMF CORPORATE ADMINISTRATION SERVICES LIMITED Corporate Secretary 2019-12-04 2024-09-01
ARCHER, Mark Adrian Director 2014-03-19 2016-08-31
DYSON, Bernard Director 2019-08-12 2022-04-07
FELDMAN, Dan Director 2014-03-19 2014-11-25
HANBURY, Trevor Paul Director 2014-10-28 2015-08-31
HAWTIN, Kurt Kenneth Reginald, Mr. Director 2017-04-01 2017-11-16
HUGHES, Neil David Director 2014-11-25 2016-08-31
SHERBET, Eric Mitchell Director 2014-01-17 2014-10-28
SPACIE, Daniel John Director 2018-08-31 2019-08-12
WONG, Theodore Xi-Chao Director 2014-03-19 2020-03-18

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Inventiv European Holdings Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Active

Filing timeline

Last 20 of 71 total filings

Date Type Category Description
2026-01-19 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-10-07 AA accounts Accounts with accounts type full
2025-02-06 CS01 confirmation-statement Confirmation statement with updates PDF
2025-02-06 AD02 address Change sail address company with old address new address PDF
2025-02-06 AD02 address Change sail address company with old address new address PDF
2025-02-06 CH01 officers Change person director company with change date PDF
2025-02-06 AD04 address Move registers to registered office company with new address PDF
2024-09-02 AP04 officers Appoint corporate secretary company with name date PDF
2024-09-02 TM02 officers Termination secretary company with name termination date PDF
2024-08-23 AA accounts Accounts with accounts type full
2024-06-27 RP04SH01 capital Second filing capital allotment shares PDF
2024-04-12 SH01 capital Capital allotment shares
2024-01-24 CS01 confirmation-statement Confirmation statement with updates PDF
2024-01-18 CH04 officers Change corporate secretary company with change date PDF
2023-11-28 AD02 address Change sail address company with old address new address PDF
2023-10-04 AA accounts Accounts with accounts type full
2023-03-31 SH01 capital Capital allotment shares PDF
2023-02-08 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-11-01 AA accounts Accounts with accounts type full
2022-04-12 TM01 officers Termination director company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
1

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page